Research project
CTU - CCTG- Crabb - A RANDOMIZED PHASE II TRIAL ASSESSING TRIMODALITY THERAPY WITH OR WITHOUT ADJUVANT DURVALUMAB TO TREAT PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
-
Research groups:
-
Lead researchers:
-
Other researchers:
-
Research funder:Queen's University at Kingston
-
Status:Active
